Lepzacitinib

Product Specifications

CAS Number

2321488-47-3

Target

JAK

Related Pathways

Stem Cells, JAK/STAT signaling, Angiogenesis, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors

Purity

0.9985

Bioactivity

Lepzacitinib is a selective, small molecule JAK1/3 inhibitor used for the treatment of atopic dermatitis and other skin diseases. As a Janus kinase inhibitor, it reduces the inflammatory response.

Smiles

N(C1=C2C(=NC=C1C(OCC)=O)NC=C2)[C@H]3CN(C(CC#N)=O)CCC3

Molecular Formula

C18H21N5O3

Molecular Weight

355.39

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

LY406566 100 µg

FAM133A (NM_173698) Human Over-expression Lysate

View Details

NBP2-50273G 0.1 mL

Mouse Monoclonal Rheb Antibody (Rheb 5D5) [DyLight 488]

View Details

033449-APC 200 µL

CD11b, NT (ITGAM, CD11B, CR3A, Integrin alpha-M, CD11 antigen-like family member B, CR-3 alpha chain, Cell surface glycoprotein MAC-1 subunit alpha, Leukocyte adhesion receptor MO1, Neutrophil adherence receptor, CD11b) (APC)

View Details

E30AOC389 100 µL

INSM1 Antibody

View Details

PVT20697 2 µg

pBlueScriptR-HMGCLL1 Plasmid

View Details

RD-Rock2-Ra-48Tests 48 Tests

Rat Rho Associated Coiled Coil Containing Protein Kinase 2 (Rock2) ELISA Kit

View Details